Stock MNKA MANUKA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Manuka, Inc.

Equities

MNKA

US04302Q1094

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 12:45:10 2024-05-09 pm EDT 		5-day change 1st Jan Change
0.03 USD -25.00% Intraday chart for Manuka, Inc. -25.00% -58.33%
2023 Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2022
Capitalization 1 130
Enterprise Value (EV) 1 130.3
P/E ratio -48.8 x
Yield -
Capitalization / Revenue 417,875,672 x
EV / Revenue 418,843,518 x
EV / EBITDA -97 x
EV / FCF 876,436,225 x
FCF Yield 0%
Price to Book -127 x
Nbr of stocks (in thousands) 112,034
Reference price 2 1.160
Announcement Date 3/31/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales - 0.007057 0.311
EBITDA 1 -0.0609 -0.2869 -1.343
EBIT 1 -0.061 -0.2903 -1.359
Operating Margin - -4,114.09% -436.98%
Earnings before Tax (EBT) 1 -0.0677 -0.3298 -1.355
Net income 1 -0.0677 -0.3298 -1.355
Net margin - -4,673.19% -435.69%
EPS 2 -0.9024 -3.282 -0.0237
Free Cash Flow - -0.1869 0.1486
FCF margin - -2,648.45% 47.79%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 7/5/22 7/5/22 3/31/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 0.06 - 0.3
Net Cash position 1 - 0.08 -
Leverage (Debt/EBITDA) -0.9727 x - -0.2241 x
Free Cash Flow - -0.19 0.15
ROE (net income / shareholders' equity) - -1,217% 299%
ROA (Net income/ Total Assets) - -52.1% -178%
Assets 1 - 0.6335 0.761
Book Value Per Share 2 -0.6500 0.9900 -0.0100
Cash Flow per Share 2 0.0300 3.900 0
Capex 1 0 0.03 0.03
Capex / Sales - 386.98% 8.36%
Announcement Date 7/5/22 7/5/22 3/31/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
MANUKA, INC. Stock Manuka, Inc.
-58.33% 3.36M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+5.33% 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.11% 105B
BIONTECH SE Stock BioNTech SE
-12.56% 22.34B
ARGENX SE Stock argenx SE
-3.70% 21.93B
GENMAB A/S Stock Genmab A/S
-6.03% 18.59B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-35.21% 18.12B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.86% 16.96B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.10% 13.7B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.57% 12.45B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. MNKA Stock
  4. Financials Manuka, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW